604 — Newton, Massachusetts

604 is a clinical research site located in Newton, Massachusetts, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

604 has participated in 1 clinical trials.

Therapeutic areas: Restless Legs Syndrome, End-Stage Renal Disease.

Sponsors: UCB BIOSCIENCES GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Newton

Browse all research sites in Massachusetts · View every site in Newton

• Mass General at Newton Wellesley Hospital
• New England Hematology Oncology/Massachusetts General Cancer Center at Newton Wellesley Hospital
• Mass General Cancer Center at Newton-Wellesley Hospital's Vernon Cancer Center
• Newton-Wellelsey Hospital
• Tufts University School of Medicine
• Mass General Cancer Center Newton-Wellesley Hospital
• Brigham & Women's Hospital
• Newton Wesley Hospital
• Newton-Wellesley Hospital- Ambulatory Pain Service
• Massachusetts General Hospital at Newton-Wellesley Hospital
• Newton Wellesley Hospital Ambulatory Care Center
• Kaplan Joint Center, Newton Wellesley Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 604?

604 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 604 conducted?

604 has 1 clinical trials on record. Their work covers Restless Legs Syndrome, End-Stage Renal Disease.

Is 604 accredited by Crixeo Clinical Trials?

604 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 604?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.